Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Efficacy and Safety of Ketamine for Depression in Patients With Cancer: A Systematic Review Publisher



Azari L1 ; Hemati H2 ; Tavasolian R3 ; Shahdab S2 ; Tomlinson SM4 ; Bobonis Babilonia M5, 6, 7, 10 ; Huang J8 ; Tometich DB9 ; Turner K7, 9, 10 ; Jim HSL7, 9, 10 ; Tabriz AA7, 9, 10
Authors
Show Affiliations
Authors Affiliations
  1. 1. University of South Florida Morsani College of Medicine, Tampa, FL, United States
  2. 2. College of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Clinical Science and Nutrition, University of Chester, England, United Kingdom
  4. 4. University of South Florida Health Libraries Morsani University of South Florida Morsani College of Medicine, Tampa, FL, United States
  5. 5. Supportive Care Medicine Department, Behavioral Medicine Services, Moffitt Cancer Center, Tampa, FL, United States
  6. 6. Department of Psychiatry and Behavioral Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, United States
  7. 7. Department of Oncological Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, United States
  8. 8. Department of Anesthesiology, Moffitt Cancer Center, Tampa, FL, United States
  9. 9. Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, United States
  10. 10. Department of Oncological Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, United States

Source: International Journal of Clinical and Health Psychology Published:2024


Abstract

Background: Management of depression in the oncology population includes supportive psychotherapeutic interventions with or without psychotropic medication, which take time to demonstrate effectiveness. Fast-acting interventions, like ketamine, can provide a rapid antidepressant effect; however, there has been limited research on effects of ketamine among cancer patients. The objective of this review is to provide an overview of research on the efficacy and safety of ketamine on depression in patients with cancer. Methods: We reviewed the published literature in MEDLINE® (via PubMed®), EMBASE, and Scopus from 1 January 1982 to 20 October 2022. We screened the retrieved abstracts against inclusion criteria and conducted a full‐text review of eligible studies. Following extraction of data from included studies, we used a framework analysis approach to summarize the evidence on using ketamine in patients with cancer. Results: All 5 included studies were randomized clinical trials conducted in inpatient settings in China. In all included studies ketamine was administered intravenously. Three studies used only racemic ketamine, and two studies used both S-ketamine and racemic ketamine. All included studies reported ketamine a tolerable and effective drug to control depression symptoms. Conclusion: Included studies showed administration of sub-anesthesia ketamine significantly improves postoperative depression among patients with cancer. © 2023 The Author(s)
Related Docs
1. Ketamine for Suicidality: An Umbrella Review, British Journal of Clinical Pharmacology (2022)
2. Genetic, Hematologic and Psychological Aspects of Leukemia, Cancer Genetics and Psychotherapy (2017)
3. Effects of Antidepressant Medication on Brain-Derived Neurotrophic Factor Concentration and Neuroplasticity in Depression: A Review of Preclinical and Clinical Studies, Avicenna Journal of Medical Biotechnology (2023)
4. Efficacy and Safety of Oral Ketamine Versus Diclofenac to Alleviate Mild to Moderate Depression in Chronic Pain Patients: A Double-Blind, Randomized, Controlled Trial, Journal of Affective Disorders (2016)
5. Prevalence of Anxiety Among Breast Cancer Patients: A Systematic Review and Meta-Analysis, Breast Cancer (2020)
6. Fabrication of a Controlled-Release Core-Shell Floating Tablet of Ketamine Hydrochloride Using a 3D Printing Technique for Management of Refractory Depressions and Chronic Pain, Polymers (2024)
7. The Relationship Between Emotional Functioning of the Eortc Qlq-C30 and a Measure of Anxiety and Depression (Hads) in Cancer Patients, International Journal of Cancer Management (2019)
Experts (# of related papers)
View all Related Experts
Shahin Akhondzadeh Basti (2)
Mohammad Akrami (1)